Second Sight Medical Products, Inc. – NASDAQ:EYES

Financial Health
0
1
2
3
4
5
6
7
8
9

Second Sight Medical Products stock price monthly change

+130.00%
month

Second Sight Medical Products stock price quarterly change

+90.34%
quarter

Second Sight Medical Products stock price yearly change

+11.89%
year

Second Sight Medical Products key metrics

Market Cap
210.04M
Enterprise value
N/A
P/E
-5.99
EV/Sales
N/A
EV/EBITDA
0.20
Price/Sales
N/A
Price/Book
0.86
PEG ratio
-0.09
EPS
-0.71
Revenue
N/A
EBITDA
-9.00M
Income
-9.07M
Revenue Q/Q
N/A
Revenue Y/Y
-74%
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Second Sight Medical Products stock price history

Second Sight Medical Products stock forecast

Second Sight Medical Products financial statements

Second Sight Medical Products, Inc. (NASDAQ:EYES): Profit margin
Sep 2021 0 -2.50M
Dec 2021 260K -1.28M -493.46%
Mar 2022 0 -2.21M
Jun 2022 0 -3.07M
Second Sight Medical Products, Inc. (NASDAQ:EYES): Debt to assets
Sep 2021 73630000 4.02M 5.46%
Dec 2021 70879000 2.51M 3.55%
Mar 2022 68538000 2.38M 3.48%
Jun 2022 65649000 2.59M 3.95%
Second Sight Medical Products, Inc. (NASDAQ:EYES): Cash Flow
Sep 2021 -1.8M 0 0
Dec 2021 -2.42M -14K 2K
Mar 2022 -1.97M -8.01M 0
Jun 2022 -3.22M 0 0

Second Sight Medical Products alternative data

Second Sight Medical Products, Inc. (NASDAQ:EYES): Employee count
Aug 2023 15
Sep 2023 15
Oct 2023 15
Nov 2023 15
Dec 2023 15
Jan 2024 15
Feb 2024 15
Mar 2024 15
Apr 2024 15
May 2024 15
Jun 2024 15
Jul 2024 15

Second Sight Medical Products other data

Second Sight Medical Products, Inc. (NASDAQ:EYES): Insider trades (number of shares)
Period Buy Sel
May 2019 0 3867
Jun 2019 0 23586
Aug 2019 0 3902
Feb 2020 0 1793
Transaction Date Insider Security Shares Price per share Total value Source
Sale
MCGUIRE JONATHAN WILL director Common Stock 1,793 $5.44 $9,754
Option
MCGUIRE JONATHAN WILL director Restricted Stock Units (RSUs) 5,532 N/A N/A
Option
RYAN WILLIAM PATRICK officer: Chief Operating Officer
Restricted Stock Units(RSUs) 3,594 N/A N/A
Option
BLAKE JOHN T officer: Chief Financial Officer
Restricted Stock Units(RSUs) 2,563 N/A N/A
Sale
MCGUIRE JONATHAN WILL director Common Stock 3,902 $0.81 $3,153
Option
MCGUIRE JONATHAN WILL director Common Stock 11,875 N/A N/A
Option
MCGUIRE JONATHAN WILL director Restricted Stock Units (RSUs) 11,875 N/A N/A
Sale
RANDOLPH EDWARD DAVID officer: Vice Pre.. Common Stock 23,586 $0.71 $16,652
Sale
MCGUIRE JONATHAN WILL director Common Stock 3,867 $0.85 $3,287
Option
MCGUIRE JONATHAN WILL director Common Stock 11,875 N/A N/A
Patent
Grant
Filling date: 29 Jan 2020 Issue date: 19 Jul 2022
Grant
Filling date: 7 Dec 2017 Issue date: 12 Apr 2022
Grant
Filling date: 23 Jul 2019 Issue date: 1 Feb 2022
Grant
Filling date: 18 Jul 2019 Issue date: 18 Jan 2022
Grant
Filling date: 16 Sep 2019 Issue date: 11 Jan 2022
Grant
Filling date: 18 Jul 2019 Issue date: 16 Nov 2021
Grant
Filling date: 18 Jul 2019 Issue date: 16 Nov 2021
Grant
Filling date: 18 Jul 2019 Issue date: 28 Sep 2021
Grant
Filling date: 17 May 2019 Issue date: 1 Jun 2021
Grant
Filling date: 24 Jun 2019 Issue date: 16 Mar 2021
Insider Compensation
Mr. Scott Dunbar (1957) Acting Chief Executive Officer
$255,300
Dr. Jessy Dana Dorn Ph.D. (1976) Vice President of Clinical & Scientific Affairs $233,990
Mr. Edward David Randolph (1958) Vice President of Operations $167,500
Mr. Edward Jonathon Sedo (1956) Acting Chief Accounting Officer & Principal Financial Officer
$151,080
  • When is Second Sight Medical Products's next earnings date?

    Unfortunately, Second Sight Medical Products's (EYES) next earnings date is currently unknown.

  • Does Second Sight Medical Products pay dividends?

    No, Second Sight Medical Products does not pay dividends.

  • How much money does Second Sight Medical Products make?

    Second Sight Medical Products has a market capitalization of 210.04M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 74% to -130K US dollars.

  • What is Second Sight Medical Products's stock symbol?

    Second Sight Medical Products, Inc. is traded on the NASDAQ under the ticker symbol "EYES".

  • What is Second Sight Medical Products's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Second Sight Medical Products?

    Shares of Second Sight Medical Products can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Second Sight Medical Products's key executives?

    Second Sight Medical Products's management team includes the following people:

    • Mr. Scott Dunbar Acting Chief Executive Officer(age: 68, pay: $255,300)
    • Dr. Jessy Dana Dorn Ph.D. Vice President of Clinical & Scientific Affairs(age: 49, pay: $233,990)
    • Mr. Edward David Randolph Vice President of Operations(age: 67, pay: $167,500)
    • Mr. Edward Jonathon Sedo Acting Chief Accounting Officer & Principal Financial Officer(age: 69, pay: $151,080)
  • How many employees does Second Sight Medical Products have?

    As Jul 2024, Second Sight Medical Products employs 15 workers.

  • When Second Sight Medical Products went public?

    Second Sight Medical Products, Inc. is publicly traded company for more then 10 years since IPO on 19 Nov 2014.

  • What is Second Sight Medical Products's official website?

    The official website for Second Sight Medical Products is secondsight.com.

  • Where are Second Sight Medical Products's headquarters?

    Second Sight Medical Products is headquartered at 12744 San Fernando Rd Bldg 3, Sylmar, CALIFORNIA.

  • How can i contact Second Sight Medical Products?

    Second Sight Medical Products's mailing address is 12744 San Fernando Rd Bldg 3, Sylmar, CALIFORNIA and company can be reached via phone at +1 818 833 5000.

Second Sight Medical Products company profile:

Second Sight Medical Products, Inc.

secondsight.com
Exchange:

NASDAQ

Full time employees:

15

Industry:

Medical - Devices

Sector:

Healthcare

As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.

12744 San Fernando Rd Bldg 3
Sylmar, CALIFORNIA 91342

CIK: 0001266806
ISIN: US81362J2096
CUSIP: 81362J209